Michela Piezzo - Dissemin

Language
Login

All papers authored by Michela Piezzo

This paper is made freely available by the publisher.

2021 Alberto Enrico Maraolo

ORCID

ORCID

, Michela Piezzo

ORCID

, Piergiacomo Di Gennaro, Maria Grazia Vitale, Domenico Mallardo

ORCID

, Luigi Ametrano

ORCID

, Egidio Celentano, Arturo Cuomo, Paolo A. Ascierto, Marco Cascella

ORCID

The Use of Tocilizumab in Patients with COVID-19: A Systematic Review, Meta-Analysis and Trial Sequential Analysis of Randomized Controlled Studies

Download from doi.org

This paper is made freely available by the publisher.

Michela Piezzo

ORCID

, Roberta D’Aniello, Ilaria Avallone, Bruno Barba, Daniela Cianniello, Stefania Cocco, Antonio D’Avino, Germira Di Gioia, Vincenzo Di Lauro, Giuseppina Fusco

ORCID

, Raffaele Piscitelli, Claudia von Arx, Michelino De Laurentiis

ORCID

, Piera Maiolino

Uptake of Trastuzumab Biosimilars for the Treatment of HER2-Positive Breast Cancer: A Real-World Experience from a Cancer Center

Download from doi.org

This paper is made freely available by the publisher.

Mauro Cozzolino

ORCID

, Stefania Cocco

ORCID

, Michela Piezzo

ORCID

, Giovanna Celia, Susan Costantini

ORCID

, Valentina Abate, Francesca Capone, Daniela Barberio, Laura Girelli, Elisa Cavicchiolo

ORCID

, Paolo Antonio Ascierto

ORCID

, Gabriele Madonna

ORCID

, Alfredo Budillon

ORCID

, Michelino De Laurentiis

ORCID

A Psychosocial Genomics Pilot Study in Oncology for Verifying Clinical, Inflammatory and Psychological Effects of Mind-Body Transformations-Therapy (MBT-T) in Breast Cancer Patients: Preliminary Results

Download from doi.org

This paper is made freely available by the publisher.

This paper is made freely available by the publisher.

Stefania Cocco

ORCID

, Alessandra Leone

ORCID

, Michela Piezzo

ORCID

, Roberta Caputo, Vincenzo Di Lauro, Francesca Di Rella, Giuseppina Fusco, Monica Capozzi, Germira di Gioia, Alfredo Budillon, Michelino De Laurentiis

ORCID

Targeting Autophagy in Breast Cancer

Download from doi.org

This paper is made freely available by the publisher.

Michela Piezzo

ORCID

, Stefania Cocco

ORCID

, Roberta Caputo, Daniela Cianniello, Germira Di Gioia, Vincenzo Di Lauro, Giuseppina Fusco

ORCID

, Claudia Martinelli, Francesco Nuzzo, Matilde Pensabene, Michelino De Laurentiis

ORCID

Targeting Cell Cycle in Breast Cancer: CDK4/6 Inhibitors

Download from doi.org

This paper is made freely available by the publisher.

Michela Piezzo

ORCID

, Paolo Chiodini, Maria Riemma, Stefania Cocco

ORCID

, Roberta Caputo, Daniela Cianniello, Germira Di Gioia, Vincenzo Di Lauro, Francesca Di Rella, Giuseppina Fusco, Giovanni Iodice, Francesco Nuzzo, Carmen Pacilio, Matilde Pensabene, Michelino De Laurentiis

ORCID

Progression-Free Survival and Overall Survival of CDK 4/6 Inhibitors Plus Endocrine Therapy in Metastatic Breast Cancer: A Systematic Review and Meta-Analysis

Download from doi.org

This paper is made freely available by the publisher.

Stefania Cocco

ORCID

, Michela Piezzo

ORCID

, Alessandra Calabrese, Daniela Cianniello, Roberta Caputo, Vincenzo Di Lauro, Giuseppina Fusco, Germira di Gioia, Marina Licenziato, Michelino de Laurentiis

ORCID

Biomarkers in Triple-Negative Breast Cancer: State-of-the-Art and Future Perspectives

Download from doi.org

This paper is made freely available by the publisher.

2018 Marina Cazzaniga, Claudio Verusio, Mariangela Ciccarese, Alberto Fumagalli, Donata Sartori, Maria Rosaria Valerio, Mario Airoldi, Gabriella Moretti, Corrado Ficorella, Valentina Arcangeli, Lucrezia Diodati, Alberto Zambelli, Antonio Febbraro, Daniele Generali, Mirco Pistelli and 23 other authors

Correction: Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: new lessons for clinical practice from the EVA study

Download from doi.org

This paper is made freely available by the publisher.

Marina Cazzaniga, Claudio Verusio, Mariangela Ciccarese, Alberto Fumagalli, Donata Sartori, Cristina Ancona, Maria Rosaria Valerio, Mario Airoldi, Gabriella Moretti, Corrado Ficorella, Valentina Arcangeli, Lucrezia Diodati, Alberto Zambelli, Antonio Febbraro, Daniele Generali and 25 other authors

Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: new lessons for clinical practice from the EVA study

Download from doi.org

This paper was not found in any repository, but could be made available legally by the author.

2017 M. E. Cazzaniga, M. Airoldi, V. Arcangeli, S. Artale, F. Atzori, A. Ballerio, G. V. Bianchi, L. Blasi, S. Campidoglio, M. Ciccarese, M. C. Cursano, M. Piezzo

ORCID

, A. Fabi, L. Ferrari, A. Ferzi and 54 other authors

Efficacy and safety of Everolimus and Exemestane in hormone-receptor positive (HR+) human-epidermal-growth-factor negative (HER2−) advanced breast cancer patients: New insights beyond clinical trials. The EVA study

Upload

This paper is made freely available by the publisher.

Gerardo Botti, Francesca Collina

ORCID

, Giosuè Scognamiglio, Federica Rao, Valentina Peluso, Rossella De Cecio, Michela Piezzo

ORCID

, Gabriella Landi, Michelino De Laurentiis, Monica Cantile, Maurizio Di Bonito

Programmed Death Ligand 1 (PD-L1) Tumor Expression Is Associated with a Better Prognosis and Diabetic Disease in Triple Negative Breast Cancer Patients

Download from doi.org

Missing publications? Search for publications with a matching author name.